The UK SmPCs for semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro), as well as their EMA European Public Assessment Reports (EPARs), document well-characterised GI side effect profiles that include nausea, vomiting, diarrhoea, constipation, and dyspepsia
Youll often see stabilized vitamin C derivatives or lower concentrations designed to deliver steady, buildable results over time, rather than that quick-hit, sometimes stinging payoff
When to Start Stacking Don't add Tesamorelin or MOTS-C on day one of Reta
A tirzepatida, substncia presente no Zepbound e no Mounjaro um agonista de GLP-1, assim como a semaglutida, do Ozempic e do Wegovy, e a liraglutida, do Saxenda
These effects are typically transient but can be exacerbated if the nasal membrane is compromised or if the user has existing sinus issues